InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,738.17
(
-0.13%
)
US TECH 100
19,436.00
(
-0.73%
)
Dow Jones
42,313.00
(
0.33%
)
Brent Oil
72.01
(
0.00%
)
Bitcoin
65,596.67
(
-0.29%
)
Post# of 253249
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

tony111

Send PM Follow Ignore
Followers 10
Posts 1064
Boards Moderated 0
Alias Born 11/24/2007

tony111

Re: DewDiligence post# 70508

Tuesday, 12/23/2008 2:00:23 PM

Tuesday, December 23, 2008 2:00:23 PM

Post# of 253249
THRX

444 is GSK's compound and THRX will have to pay 200M milestone to GSK when the drug is approved. Also, Advair will go off patent in 2010. Dew about IDIX its almost the end of 2008 and we haven't heard of a partnership. If there is no deal before 2008, how will it affect the stock price?
http://www.pharmaceutical-business-review.com/article_feature.asp?guid=7221D076-7BBB-4BF3-95C1-80B770898D60

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up